EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lutein-in-Extra-Virgin-Olive-Oil Supplementation as a Multifaceted Nutritional Intervention for Retinopathy of Prematurity: Evidence from the Mouse Oxygen-Induced Retinopathy Model

Xiaoyuan Ye iD, Lu Xiang iD, Ka Yee Chen iD, Leo O Lai, Jetty Chung-Yung Lee iD, Antonia M Joussen, Wai-Ching Lam, Amy C Y Lo iD

Nutrients · 30.10.2026 · 18 (21) · 3616

DOI: 10.3390/nu18213616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 30.10.2026. Verfasst von Xiaoyuan Ye und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Lutein, Dietary Supplements, Olive Oil. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Retinopathy of prematurity (ROP) is a predominant contributor to preventable childhood blindness driven by oxidative stress and inflammation, but with limited treatment options. Safe, non-invasive adjunctive strategies become attractive. Lutein displays antioxidant and anti-inflammatory properties, but its clinical efficacy remains controversial. We proposed that formulating lutein in extra-virgin olive oil (EVOO) might enhance its absorption and efficacy in ROP. Here, we evaluated the effects of lutein-in-EVOO (LEVOO) in oxygen-induced retinopathy (OIR), a mouse model of ROP.

Methods

C57BL/6J mouse neonates received daily gavage of LEVOO (0.4 μg/g, 1.8 μg/g and 3.6 μg/g of lutein in EVOO) after OIR challenge from postnatal day (P) 12 to P16. Assessments were conducted at P17, including retinal vasculature, function, cytoarchitecture, inflammation, and oxidative damage; serum biochemical and antioxidant profiles; and proteomic analysis and targeted retinal metabolomic analysis.

Results

Oral supplementation of LEVOO was well-tolerated and safe in mouse neonates. It reduced retinal avascular and neovascular areas, increased electroretinographic b-wave amplitudes, and restored amacrine cells and rod bipolar cells. LEVOO administration reduced oxidative damage and activated microglia. LEVOO administration inhibited the hypoxia-inducible factor-1α (HIF-1α)/macrophage migration inhibitory factor (MIF) signaling and low-density lipoprotein receptor-related protein-1 (LRP1)-dependent cyclophilin A (CypA)/matrix metalloproteinase-9 (MMP9) signaling. It also helped to partially restore retinal docosahexaenoic acid and dopamine in OIR mice.

Conclusions

LEVOO demonstrated multifaceted efficacy in OIR. It reconstructed retinal vasculature, restored retinal function, and rescued neuronal cell loss with strong antioxidative and anti-inflammatory effects. Collectively, these findings establish LEVOO as a promising non-invasive complementary strategy for ROP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinopathy of PrematurityLuteinDietary SupplementsOlive OilAnimalsMice, Inbred C57BLDisease Models, AnimalOxygenMiceOxidative StressAnimals, NewbornAntioxidantsRetinaMale

Stichwörter der Autor:innen

blood-retinal barrier (BRB)carotenoidinflammationischemic retinopathymetabolitesneovascularization

Substanzen

LuteinOlive OilOxygenAntioxidants

Autor:innen und Institutionen

  • Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China.
  • School of Biological Sciences, The University of Hong Kong, Hong Kong 999077, China.
  • Department of Ophthalmology, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.
  • Department of Ophthalmology, Vancouver General Hospital, University of British Columbia, Vancouver, BC V5Z 3N9, Canada.

ORCID-Profile: Xiaoyuan Ye, Lu Xiang, Ka Yee Chen, Jetty Chung-Yung Lee, Amy C Y Lo

Förderung

  • Health and Medical Research Fund

Zitieren

APA

Ye, X., Xiang, L., Chen, K. Y., Lai, L. O., Lee, J. C., Joussen, A. M., Lam, W. C., & Lo, A. C. Y. (2026). Lutein-in-Extra-Virgin-Olive-Oil Supplementation as a Multifaceted Nutritional Intervention for Retinopathy of Prematurity: Evidence from the Mouse Oxygen-Induced Retinopathy Model. Nutrients, 18(21), 3616. https://doi.org/10.3390/nu18213616

Vancouver

Ye X, Xiang L, Chen KY, Lai LO, Lee JC, Joussen AM, et al. Lutein-in-Extra-Virgin-Olive-Oil Supplementation as a Multifaceted Nutritional Intervention for Retinopathy of Prematurity: Evidence from the Mouse Oxygen-Induced Retinopathy Model. Nutrients. 2026;18(21):3616. doi:10.3390/nu18213616

BibTeX
@article{Ye2026,
  author = {Ye, Xiaoyuan and Xiang, Lu and Chen, Ka Yee and Lai, Leo O and Lee, Jetty Chung-Yung and Joussen, Antonia M and Lam, Wai-Ching and Lo, Amy C Y},
  title = {Lutein-in-Extra-Virgin-Olive-Oil Supplementation as a Multifaceted Nutritional Intervention for Retinopathy of Prematurity: Evidence from the Mouse Oxygen-Induced Retinopathy Model},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3616},
  doi = {10.3390/nu18213616}
}
Kostenlos starten →